You are here

Guidance 18: Impurities in drug substances and drug products

(Updated from ARGPM Appendix 18: Impurities in active pharmaceutical ingredients and finished products)

9 August 2013

Book pagination

This guidance provides sponsors with the information requirements relating to impurities in prescription medicines entered in the Australian Register of Therapeutic Goods (ARTG).


Version history

Version Description of change Author Effective date
V1.0 Original publication Office of Medicines Authorisation 09/08/2013

Book pagination